Charlotte's Web Holdings (CWBHF) Liabilities and Shareholders Equity (2020 - 2026)
Charlotte's Web Holdings (CWBHF) reported Liabilities and Shareholders Equity of $70.7 million for Q1 2026, down 34.56% year-over-year from $108.0 million in Q1 2025, and down 6.09% quarter-over-quarter from $75.3 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $70.7 million in Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $70.7 million, down 34.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $315.5 million (down 32.99% YoY), and the FY2025 annual result was $75.3 million, down 33.65% from the prior year.
- Liabilities and Shareholders Equity declined to $70.7 million in Q1 2026 per CWBHF's latest filing, from $75.3 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $187.6 million in Q4 2022 and troughed at $70.7 million in Q1 2026.
- A 5-year average of $131.7 million and a median of $140.5 million in 2022 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2023 and 2026: Liabilities and Shareholders Equity climbed 16.62% in 2023, then slumped 34.56% in 2026.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $187.6 million in 2022, then declined by 18.7% to $152.5 million in 2023, then fell by 25.64% to $113.4 million in 2024, then slumped by 33.65% to $75.3 million in 2025, then decreased by 6.09% to $70.7 million in 2026.
- Business Quant data shows CWBHF's Liabilities and Shareholders Equity at $70.7 million in Q1 2026, $75.3 million in Q4 2025, and $81.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 40.04 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 15.15 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.71 Bn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 4.91 Bn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 13.22 Bn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 4.26 Bn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 2.35 Bn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 401.53 Mn |
| 10 | Charlotte's Web Holdings | - | - | 5.20 Mn | 70.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.69 Mn |
| Dec 31, 2025 | 75.27 Mn |
| Sep 30, 2025 | 81.60 Mn |
| Jun 30, 2025 | 87.98 Mn |
| Mar 31, 2025 | 108.02 Mn |
| Dec 31, 2024 | 113.44 Mn |
| Sep 30, 2024 | 119.64 Mn |
| Jun 30, 2024 | 129.79 Mn |
| Mar 31, 2024 | 141.78 Mn |
| Dec 31, 2023 | 152.55 Mn |
| Sep 30, 2023 | 163.87 Mn |
| Jun 30, 2023 | 176.59 Mn |
| Mar 31, 2023 | 175.97 Mn |
| Dec 31, 2022 | 187.64 Mn |
| Sep 30, 2022 | 140.52 Mn |
| Jun 30, 2022 | 153.01 Mn |
| Mar 31, 2022 | 160.82 Mn |
| Dec 31, 2021 | 171.51 Mn |
| Dec 31, 2020 | 310.79 Mn |